Home Blog Page 1964

Jiuzi Holdings, Inc. Partners with SOLV Foundation on $2.8B TVL Bitcoin Initiative to Advance Crypto Treasury Strategy

By
Advertorial Desk
-

HANGZHOU, China, Oct. 27, 2025 /PRNewswire/ — Jiuzi Holdings, Inc. (NASDAQ: JZXN; “the Company”) today announced it has entered into a Strategic Cooperation Agreement with the SOLV Foundation, a cross-chain Bitcoin staking and structured finance platform boasting a total value locked (TVL) of US$2.8 billion. This collaboration underscores the Company’s ambition as a Nasdaq-listed leader focused on building its treasury around Bitcoin as its primary digital asset holding.

JZXN will leverage SOLV’s platform to maximize the efficiency of its Bitcoin holdings. Bitcoin assets held by the Company or its subsidiaries will be deposited into the SOLV platform under custody by approved, regulated third parties designated by the Company, ensuring transparency, security, and institutional-grade auditability.

Furthermore, senior representatives from both JZXN and SOLV will form a Steering Committee tasked with spearheading transformative initiatives to redefine Bitcoin-centric decentralized finance (DeFi). This committee will drive adoption of SolvBTC across networks including Solana, Base; facilitate market expansion; and pioneer innovative financial models such as tokenized real-world assets and structured yield products.

This agreement reflects the shared vision of positioning the Company as a Bitcoin-focused crypto financial firm, integrating its reserves with cutting-edge digital asset strategies. By tapping into SOLV’s expertise in Bitcoin liquidity aggregation and staking, JZXN aims to provide shareholders with institutional exposure to Bitcoin while enhancing capital efficiency within a regulated framework. Both parties affirm that this partnership will operate under principles of transparency, sound governance, and compliance with U.S. Securities and Exchange Commission (SEC) regulations and Nasdaq listing requirements.

Mr. Li Tao, Chief Executive Officer of Jiuzi Holdings, Inc., stated: “This partnership marks a transformative step forward, strengthening our Bitcoin vault strategy and aligning us with one of the most advanced platforms in the Bitcoin liquidity and staking ecosystem.”

Ryan Chow, Co-Founder of Solv Protocol, said, “Our expertise in managing large-scale Bitcoin assets, combined with Jiuzi’s NASDAQ-listed status, builds a bridge of trust for traditional finance. Together, we’re enabling secure institutional capital flow into crypto.”

About Jiuzi Holdings, Inc.

Jiuzi Holdings, Inc. is a leading provider of NEV intelligent charging infrastructure in China’s lower-tier cities. The Company specializes in high-power DC fast charging stations integrated with energy storage systems and plans continued expansion through 2026 to support China’s carbon neutrality goals and sustainable transportation. For more information, visit jzxn.com.

 

Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment with FDA initiative Project FrontRunner

By
Advertorial Desk
-

SYDNEY, Oct. 27, 2025 /PRNewswire/ — Kazia Therapeutics Limited (“Kazia” or the “Company”) today announced its intention to request and hold a follow-up Type C meeting with the U.S. Food & Drug Administration (FDA) to discuss overall survival (OS) findings in newly diagnosed glioblastoma (GBM) patients treated with paxalisib and to seek agency feedback on a potential regulatory pathway aligned with the FDA Oncology Center of Excellence’s Project FrontRunner initiative.

“GBM remains one of the most lethal cancers with limited therapeutic options. In line with the FDA Oncology Center of Excellence’s Project FrontRunner initiative, we intend to engage the Agency to discuss whether the overall survival data generated in newly diagnosed GBM patients treated with paxalisib may be adequate to support a conditional approval pathway,” said Dr. John Friend, M.D., Chief Executive Officer of Kazia Therapeutics. “Consistent with this framework, Kazia will propose initiation of the post-approval, randomized Phase 3 confirmatory study prior to submission of the NDA, ensuring that our regulatory strategy fully reflects the FDA’s renewed emphasis on overall survival as the most meaningful endpoint for patients and clinicians.”

In its recently issued draft guidance, the FDA stated that overall survival is the “gold standard” endpoint in oncology and “should be prioritized as the primary endpoint when feasible,” particularly in diseases with a short natural history where survival can be reliably assessed. Kazia believes GBM is precisely such a setting and intends to present survival analyses, supporting clinical safety, and planned confirmatory trial design for FDA discussion.

Project FrontRunner is an FDA Oncology Center of Excellence initiative encouraging sponsors to consider when it may be appropriate to seek approval of cancer drugs for advanced or metastatic disease in an earlier clinical setting, rather than the traditional approach of developing therapies only for patients who have exhausted available treatment options.

As announced in July 2024, in the prespecified secondary analysis in newly diagnosed (up-front) unmethylated GBM patients, median OS was 15.54 months in the paxalisib arm (n = 54) versus 11.89 months for concurrent standard of care (SOC) (n = 46). Kazia intends to reference Project FrontRunner principles in its Type C briefing package, including an OS-driven confirmatory study plan in newly diagnosed GBM.

“We are moving decisively to bring paxalisib forward in GBM using the endpoints that matter most to patients and physicians,” added Dr. Friend. “Our objective is to work collaboratively with the FDA under the guiding principles of Project FrontRunner to pursue a conditional approval in the front-line treatment setting of glioblastoma. In parallel, Kazia will initiate the post-approval, randomized Phase 3 study prior to filing the NDA, ensuring that our development plan fully aligns with the Agency’s modernized, patient-focused framework.”

Kazia also notes that leading oncology companies have begun publicly referencing Project FrontRunner in successful FDA actions, underscoring the initiative’s growing relevance for sponsors developing first-line or earlier-setting therapies.

For investor and media, please contact Alex Star, Managing Director LifeSci Advisors LLC, Astarr@lifesciadvisors.com, +1-201-786-8795.

About Kazia Therapeutics Limited

Kazia Therapeutics Limited (NASDAQ: KZIA) is an oncology-focused drug development company, based in Sydney, Australia. Our lead program is paxalisib, an investigational brain penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of cancer. Licensed from Genentech in late 2016, paxalisib is or has been the subject of ten clinical trials in this disease. A completed Phase 2/3 study in glioblastoma (GBM-Agile) was reported in 2024 and discussions are ongoing for designing and executing a pivotal registrational study in pursuit of a standard approval. Other clinical trials involving paxalisib are ongoing in advanced breast cancer, brain metastases, diffuse midline gliomas, and primary central nervous system lymphoma, with several of these trials having reported encouraging interim data. Paxalisib was granted Orphan Drug Designation for glioblastoma by the U.S. Food and Drug Administration (FDA) in February 2018, and Fast Track Designation (FTD) for glioblastoma by the FDA in August 2020. Paxalisib was also granted FTD in July 2023 for the treatment of solid tumor brain metastases harboring PI3K pathway mutations in combination with radiation therapy. In addition, paxalisib was granted Rare Pediatric Disease Designation and Orphan Drug Designation by the FDA for diffuse intrinsic pontine glioma in August 2020, and for atypical teratoid / rhabdoid tumors in June 2022 and July 2022, respectively. Kazia is also developing EVT801, a small molecule inhibitor of VEGFR3, which was licensed from Evotec SE in April 2021. Preclinical data has shown EVT801 to be active against a broad range of tumor types and has provided evidence of synergy with immuno-oncology agents. A Phase I study has been completed and preliminary data was presented at 15th Biennial Ovarian Cancer Research Symposium in September 2024. For more information, please visit www.kaziatherapeutics.com or follow us on X @KaziaTx.

Forward-Looking Statements

This announcement contains forward-looking statements, which can generally be identified as such by the use of words such as “may,” “will,” “plan,” “intend,” “estimate,” “future,” “forward,” “potential,” “anticipate,” or other similar words. Any statement describing Kazia’s future plans, strategies, intentions, expectations, objectives, goals or prospects, and other statements that are not historical facts, are also forward looking statements, including, but not limited to, statements regarding: Kazia’s intention to request and hold a Type C meeting with the FDA to discuss OS findings in GBM patients treated with paxalisib and to seek agency feedback on a potential regulatory pathway, the plan to propose initiation of the post-approval, randomized Phase 3 confirmatory study prior to submission of the NDA, the intention to present survival analyses, supporting clinical safety and planned confirmatory trial design for FDA discussion, Kazia’s intention to reference Project FrontRunner principles in its Type C briefing package, the objective to work collaboratively with the FDA under the guiding principles of Project FrontRunner, the plan to pursue a conditional approval in the front-line treatment setting of GBM, the plan to initiate the post-approval, randomized Phase 3 study prior to filing the NDA, the goal of ensuring that Kazia’s development plan and regulatory strategy fully reflects and aligns with the FDA’s framework and emphasis, the timing for results and data related to Kazia’s clinical and preclinical trials, Kazia’s strategy and plans with respect to its paxalisib program, the potential benefits of paxalisib, timing for any regulatory submissions or discussions with regulatory agencies and the potential market opportunity for paxalisib. Such statements are based on Kazia’s current expectations and projections about future events and future trends affecting its business and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements, including risks and uncertainties associated with clinical and preclinical trials and product development, including the risk that interim or early data may not be consistent with final data, risks related to regulatory approvals, risks related to the impact of global economic conditions and U.S. government shutdown, and risks related to Kazia’s ability to regain and/or maintain compliance with the applicable Nasdaq continued listing requirements and standards. These and other risks and uncertainties are described more fully in Kazia’s Annual Report, filed on form 20-F with the SEC, and in subsequent filings with the United States Securities and Exchange Commission. Kazia undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required under applicable law. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this announcement.

ISX Financial EU PLC Appoints Group CFO Ajay Treon to the Board of Directors as Executive Director

By
Advertorial Desk
-

NICOSIA, Cyprus, Oct. 27, 2025 /PRNewswire/ — ISX Financial EU Plc (“ISXX”), an EEA-authorised Electronic Money Institution and banktech provider of transactional banking and real-time payments across Europe and the UK, is pleased to announce the appointment of Mr. Ajay Treon, Group Chief Financial Officer, as an Executive Director on the Company’s Board of Directors. The appointment follows a non-objection by the Eurosystem Central Bank of Cyprus, home regulator of ISXX.

With an impressive 25-year career in the banking industry, including extensive experience in renowned institutions such as Lloyds Banking Group, Lehman Brothers, Dresdner Kleinwort Investment Bank, and Credit Suisse, Mr. Treon brings a wealth of expertise in financial management, strategic planning, and risk mitigation. He also possesses valuable experience in the fintech sector, further enhancing his understanding of the evolving financial landscape. Mr. Treon is a qualified accountant, holds an Executive MBA, and possesses the esteemed Certificate in Quantitative Finance.

Since Mr. Treon assumed the role of Group Chief Financial Officer in July 2023, ISXX has delivered sustained profitability and rigorous cost discipline, including record performance in 2024 and continued resilience throughout 2025. The Group has strengthened Own Funds and Net Assets, maintained robust EBITDA margins, and continued to invest in innovation, core technology, and talent to support scale. Treasury, safeguarding, and reporting frameworks have been enhanced, aligning capital deployment with growth in open banking (A2A), e-money, and acquiring operations.

Mr. Takis Taoushanis, ISXX Chairman of the Board of Directors, said: “Mr. Treon’s appointment strengthens the Board’s financial and risk oversight at a time when settlement infrastructure, safeguarding, and capital discipline are central to execution. His vast experience across tier-one institutions and his contribution to ISXX’s recent performance make him a valuable addition to the Board of Directors.”

Mr. Ajay Treon, Group CFO and Executive Director of ISXX, said: “I am honoured to join the Board of Directors and remain fully committed to advancing the Company’s strategic priorities, strengthening capital resilience, scaling our transactional banking capabilities, and maintaining rigorous financial governance. Our focus continues to be on delivering consistent, profitable growth through operational discipline and transparent reporting, as we execute on our expanding product portfolio and market strategy.”

Mr. Nikogiannis Karantzis, ISXX Managing Director & CEO, commented: “Mr. Treon’s appointment to the Board formalises the financial and risk discipline he has helped embed across the ISXX Group, and supports our execution as we scale transactional banking and Open Banking services across the EU and UK.”

About ISX Financial EU PLC
Headquartered in Nicosia, ISX Financial EU Plc (ISXX, LEI: 213800NGHVYL5PFZI692) is a leading banktech company EEA authorised as an Electronic Money Institution by the Central Bank of Cyprus and regulated in the UK by the Financial Conduct Authority.

Website: www.isx.financial

Logo: https://laotiantimes.com/wp-content/uploads/2025/10/isx_logo-1.jpg

Iridium Unveils Revolutionary Global GPS Device Protection on a Chip

By
Advertorial Desk
-

Devices reliant on GPS and other Global Navigation Satellite Systems (GNSS) can integrate comprehensive protection against jamming, spoofing and time interruptions with the Iridium PNT ASIC

MCLEAN, Va., Oct. 27, 2025 /PRNewswire/ — Iridium Communications Inc. (NASDAQ: IRDM), a leading provider of global voice, data, and PNT satellite communications, today announced a leap forward in the security of GPS and other GNSS-reliant devices against jamming, spoofing and timing interruptions with the unveiling of a dedicated, miniature application-specific integrated circuit (ASIC), the Iridium® PNT ASIC. Engineered for seamless integration into a wide range of electronic devices, the Iridium PNT ASIC will deliver authenticated, pole-to-pole positioning, navigation, and timing (PNT) data. It will provide a resilient alternative to traditional GNSS, offering protection against spoofing and jamming for consumer, industrial, and government applications.

Iridium PNT ASIC
Iridium PNT ASIC

“This is a first. To provide this type of capability on a global basis has never been done before,” said Iridium CEO Matt Desch. “The size, low cost, and scalability of this solution to protect GPS is a major breakthrough.”

The jamming and spoofing of GNSS systems have gone from being an occasional threat to a near constant occurrence over the past few years. Several high profile events, like the September 2025 jamming of European Commission President Ursula von der Leyen’s aircraft navigation system and a malfunction of GNSS systems in the waters outside of Qatar, causing a pause in maritime operations in October 2025, are two recent examples. A September 2024 report from OPSGROUP cited a 500% increase in the spoofing of commercial airliners, specifically stating that on average 1,500 flights a day are encountering GPS spoofing.

Couple this dramatic rise in threats with the economic risks, estimated at billions of dollars per day globally, and the need for a simple, easily integrated solution is undeniable. For example, in 2019, a single day GPS outage in the United States was estimated by the U.S. National Institute of Standards and Technology (NIST) to cost the economy approximately $1 billion. When adjusted for inflation in 2025, this could be well over $1.3 billion per day.

Tiny Form Factor – Embedded Resilience

Measuring just 8mm by 8mm and capable of fitting into devices ranging from consumer products up through major infrastructure systems like power grids, transportation systems and telecom networks, the Iridium PNT ASIC democratizes GNSS resilience. When embedded in a device, the Iridium PNT ASIC receives a cryptographically secure time and location data signal from the Iridium satellite network that is 1,000 times more powerful than GPS and capable of working inside buildings. This can help GNSS-dependent applications to not only detect a problem but also maintain operations until it is resolved. The Iridium PNT ASIC will also continuously verify signal integrity, making it the ideal alternative or primary source of PNT data.

“The market for alternative PNT solutions is shifting rapidly toward compact, integrated technologies,” said Mike O’Connor, executive vice president, PNT, Iridium. “While Iridium PNT is already available in some systems, the Iridium PNT ASIC will take it to the next level to deliver the only truly global alternative to GPS in the smallest form factor available.”

The alternative PNT market is expected to reach $3.5 billion by 2032, driven by demand for secure, reliable timing and location data across all sectors of critical infrastructure. Available today, Iridium PNT protects digital infrastructure for financial markets, governments, and major corporations. Its applications span data centers, 5G wireless networks, aviation, maritime, land mobile, and IoT, making it a foundational service for the future of secure, connected systems.

“Whether in government, enterprise, or consumer applications, every device that relies on GNSS needs a dependable backup or reliable primary service in the event of disruption,” O’Connor said. “The Iridium PNT ASIC delivers that dependability in a compact, all-in-one chip.”

Iridium showcased the ASIC’s capabilities during last month’s Jammertest, an annual event that evaluates the resilience of GNSS and alternative PNT technologies under jamming and spoofing attacks. The Iridium PNT ASIC maintained both timing accuracy and reliable navigation during controlled exercises.

Iridium is inviting organizations to apply to participate in beta trials, and, if selected, they will receive Iridium PNT ASIC evaluation kits, enabling early integration and testing. The Iridium PNT ASIC is planned for commercial availability in mid-2026.

Organizations with devices that rely on GNSS and are seeking to enhance resilience against jamming, spoofing or time and frequency interruptions, or those developing innovative technologies in the PNT domain, are encouraged to learn more and express interest at www.iridium.com/pnt/asic.

Iridium is highlighting the Iridium PNT ASIC at the International Timing and Sync Forum (ITSF), held October 27th to 30th in Prague.

About Iridium Communications Inc.

Iridium® is the only mobile voice and data satellite communications network that spans the entire globe. Iridium enables connections between people, organizations, and assets to and from anywhere, in real time. Together with its ecosystem of partner companies, Iridium delivers an innovative and rich portfolio of reliable solutions for markets that require truly global communications. In 2024, Iridium acquired Satelles and its positioning, navigation, and timing (PNT) service. Iridium Communications Inc. is headquartered in McLean, Va., U.S.A., and its common stock trades on the Nasdaq Global Select Market under the ticker symbol IRDM. For more information about Iridium products, services, and partner solutions, visit www.iridium.com.

Forward-Looking Statements Disclosure

Statements in this press release that are not purely historical facts may constitute forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. The Company has based these statements on its current expectations and the information currently available to us. Forward-looking statements in this press release include statements regarding the capabilities, benefits and availability of the Iridium PNT ASIC and related services. Forward-looking statements can be identified by the words “anticipates,” “may,” “can,” “believes,” “expects,” “projects,” “intends,” “likely,” “will,” “to be” and other expressions that are predictions or indicate future events, trends or prospects. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Iridium to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, uncertainties regarding the development, marketing and availability of the Iridium PNT ASIC and related services, and the company’s ability to maintain the health, capacity and content of its satellite constellation, as well as general industry and economic conditions, and competitive, legal, governmental and technological factors. Other factors that could cause actual results to differ materially from those indicated by the forward-looking statements include those factors listed under the caption “Risk Factors” in the Company’s Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (the “SEC”) on February 13, 2025, as well as other filings Iridium makes with the SEC from time to time. There is no assurance that Iridium’s expectations will be realized. If one or more of these risks or uncertainties materialize, or if Iridium’s underlying assumptions prove incorrect, actual results may vary materially from those expected, estimated or projected. Iridium’s forward-looking statements speak only as of the date of this press release, and Iridium undertakes no obligation to update forward-looking statements.

Press Contact:  

Investor Contact:

Jordan Hassin    

Kenneth Levy

Iridium Communications Inc.   

Iridium Communications Inc.

Jordan.Hassin@Iridium.com    

Ken.Levy@Iridium.com

+1 (703) 287-7421  

+1 (703) 287-7570

 

 

CTF Life Harnesses the CTF Group Ecosystem to Forge Strategic Alliances with Three Major Hospitals Enhances Hospital and PrimeChamp Doctor Network to Empower Customers with Greater Autonomy, Convenience and Comprehensive Medical Services

By
Advertorial Desk
-

HONG KONG SAR – Media OutReach Newswire – 27 October 2025 – CTF Life today announced the signing of a Memorandum of Understanding with Gleneagles Hospital Hong Kong (“Gleneagles”), CUHK Medical Centre (“CUHKMC”), and Hong Kong Baptist Hospital (“HKBH”) to establish strategic partnerships. In a pioneering move, CTF Life has also become the first insurance company to collaborate with Gleneagles MediCentre in Admiralty to launch an exclusive programme to provide customers with health management solutions. At the same time, the PrimeChamp Doctor Network has been enhanced with the official inclusion of the three hospitals and their affiliated medical centres. This expanded medical network now spans across Hong Kong, offering customers priority referrals, appointment scheduling and direct billing services.

Man Kit Ip, Executive Director and Chief Executive Officer of CTF Life (middle); Ellick Tsui, Executive Director, Deputy Chief Executive Officer and Chief Financial Officer of CTF Life (second from right); Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong (second from left); Dr Chung Kin Lai, Chief Executive Officer of CUHK Medical Centre (first from right); and Dr Leung Chi Bon, Chief Executive Officer of Hong Kong Baptist Hospital (first from left), announce the establishment of strategic partnerships at the kick-off ceremony.
Man Kit Ip, Executive Director and Chief Executive Officer of CTF Life (middle); Ellick Tsui, Executive Director, Deputy Chief Executive Officer and Chief Financial Officer of CTF Life (second from right); Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong (second from left); Dr Chung Kin Lai, Chief Executive Officer of CUHK Medical Centre (first from right); and Dr Leung Chi Bon, Chief Executive Officer of Hong Kong Baptist Hospital (first from left), announce the establishment of strategic partnerships at the kick-off ceremony.

Man Kit Ip, Executive Director and Chief Executive Officer of CTF Life, said, “We are pleased to forge long-term business partnerships with three leading and distinguished hospitals. Harnessing the strengths of the Chow Tai Fook Group ecosystem, we are committed to providing our customers with more flexible and superior medical service solutions, serving as their Life Planner. This collaboration not only further solidifies our medical network across Hong Kong, but also elevates the overall service experience at CTF Life, empowering customers with greater autonomy, convenience and comprehensive medical service experiences at every stage of their life journey. We firmly believe that medical protection should go beyond claims, it should accompany our customers across every stage from prevention and diagnosis to treatment and recovery, truly bringing to life our vision of creating value beyond healthcare.”

Territory-wide Medical Network Coverage Across Hong Kong

The three hospitals will respectively serve as CTF Life’s designated medical network partners on Hong Kong Island, Kowloon, and the New Territories. Their doctors and mental health therapists will also join the PrimeChamp Doctor Network, providing customers with convenient, high-quality, and comprehensive medical services.

Hong Kong Island: Gleneagles Hospital Hong Kong

Gleneagles serves as the appointed medical network partner for Hong Kong Island. CTF Life has also become the first insurance company to collaborate with the newly opened Gleneagles MediCentre in Admiralty, further expanding its service scope through exclusive programmes. These programmes include gastroscopy, colonoscopy and wart removal services, providing customers with prevention-oriented health management solutions.

New Territories: CUHK Medical Centre

CUHKMC will serve as the selected medical network partner for the New Territories. Backed by a top-tier medical team comprising professors from the CUHK Faculty of Medicine and specialists, coupled with advanced medical facilities and strong research capabilities, CUHKMC provides customers with premium, multi-specialty medical services. Dedicated to translating cutting-edge international medical research into clinical practice, CUHKMC delivers a world-class diagnostic and treatment experience that benefits both customers and the wider community.

Kowloon: Hong Kong Baptist Hospital

HKBH will serve as the designated medical network partner for Kowloon. Operating under a “One Hospital, Multiple Service Sites” synergy model, the hospital enables patients to conveniently access medical services close to their preferred location. Among these sites, the HKBH East Kowloon Medical Centre (EKMC), located in the Kwun Tong Business District (Ngau Tau Kok), provides pre-approved direct billing services for cataract surgery and oncology treatments. Additionally, mental health team offers professional guidance to help individuals better understand and manage their psychological well-being. Together, these services embrace the Hospital mission: “In the Service of Man, for the Glory of God.”

Customer-Exclusive Medical Services Reflects a People-Centric Approach

Through this collaboration, the three hospitals will offer the following services for CTF Life customers:

  • Priority referral and appointment scheduling, significantly reducing waiting time.
  • Direct billing services, allowing customers to receive treatment without upfront payment, easing financial pressure.
  • One-stop cancer treatment services, covering diagnosis, treatment, and post-surgery rehabilitation, providing comprehensive support throughout the care journey.
  • Access to premium medical services and coordination, arranging professor-level doctors and advanced medical facilities to ensure customers receive the highest quality of medical care.

Hashtag: #CTFLife #周大福人壽

The issuer is solely responsible for the content of this announcement.

About CTF Life

Chow Tai Fook Life Insurance Company Limited (“CTF Life”) is proud of its rich, 40-year legacy in Hong Kong. CTF Life is a wholly-owned subsidiary of CTF Services Limited (“CTFS”) (Hong Kong Stock Code: 659) and one of the most well-established life insurance companies in Hong Kong. As a member of Chow Tai Fook Enterprises Limited, CTF Life consistently strengthens its collaboration with the Chow Tai Fook Group ecosystem to support customers and their loved ones in navigating life’s journey with personalised planning solutions, lifelong protection and diverse lifestyle experiences. By leveraging the Group’s robust financial strength and strategic investments across the globe, CTF Life aspires to become a leading insurance company in Asia while continuously creating value beyond insurance.

JinkoSolar Supplied Modules to Trinity Energy for Costco Warehouse in Washington State

By
Advertorial Desk
-

CAMPBELL, Calif., Oct. 27, 2025 /PRNewswire/ — JinkoSolar Holding Co., Ltd. (the “Company,” or “JinkoSolar”) (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that the company has supplied modules to Trinity Energy for a Costco Warehouse in the State of Washington.    

Approximately 1,000 EAGLE® G6 modules were installed at Costco in Richland, Washington. The project was registered with JinkoSolar’s EAGLE® Preserve, which recently became Washington State’s first approved solar stewardship program. For any modules at this Costco site that reach end-of-life, EAGLE® Preserve will pick up those modules at no cost to Trinity or Costco and ensure those modules are recycled in a sustainable way. 

“JinkoSolar is pleased to supply market leading EAGLE® G6 modules in conjunction with EAGLE® Preserve in Washington State,” said Nigel Cockroft, General Manager of JinkoSolar (U.S) Inc. “It is rewarding to work with Trinity who, like JinkoSolar, cares deeply about sustainability and circular economy.”

“JinkoSolar is helping us build a creative and effective solar project solution for Costco,” said Darin Leonard, President of Trinity Structures. “As a Washington company, it is important that we work with a company like JinkoSolar whose modules are the first in the sector to comply with the Washington recycling law.”

“Trinity is helping businesses like Costco achieve their sustainability commitments while ensuring operations are not impacted due to a lack of available energy,” said Tim Owen, Chief Operations Officer for Trinity Energy. “Responsibly recycling modules at end-of-life highlights our combined focus on eliminating harmful environmental impacts.”

About JinkoSolar Holding Co., Ltd.

JinkoSolar (NYSE: JKS) is one of the largest and most innovative solar module manufacturers in the world. JinkoSolar distributes its solar products and sells its solutions and services to utility-scale, commercial and residential customers in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, Netherlands, Poland, Austria, Switzerland, Greece and other countries and regions.

JinkoSolar had 10 productions facilities globally, over 20 overseas subsidiaries in Japan, South Korea, Vietnam, India, Turkey, Germany, Italy, Switzerland, the United States, Mexico, and other countries, and a global sales network with sales teams in China, the United States, Canada, Brazil, Chile, Mexico, Italy, Germany, Turkey, Spain, Japan, the United Arab Emirates, Netherlands, Vietnam and India, as of June 30, 2025.

To find out more, please see: www.jinkosolar.com

About Trinity Structures

Trinity Energy is a leader in off-grid, renewable electrification solutions that help organizations achieve energy independence, resilience, and sustainability. Specializing in modular energy systems that generate, store, and distribute solar power. Trinity serves key sectors including fleet, hospitality, commercial, and multi-family housing. Trinity transforms energy from a utility cost into a strategic business asset. For more information about Trinity Energy and its innovative energy solutions, visit www.TrinityEnergy.net.

Safe-Harbor Statement

This press release contains forward-looking statements. These statements constitute “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends, “plans,” “believes,” “estimates” and similar statements. Among other things, the quotations from management in this press release and the Company’s operations and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in JinkoSolar’s filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

For investor and media inquiries, please contact:

Ms. Stella Wang
JinkoSolar Holding Co., Ltd.
Tel: +86 21-5180-8777 ext.7806
Email: pr@jinkosolar.com

Shanghai Commercial Bank Unveils “From Shanghai to Hong Kong, Connecting the World” Exhibition To Mark Its 75th Anniversary

By
Advertorial Desk
-

HONG KONG SAR – Media OutReach Newswire – 27 October 2025 – Shanghai Commercial Bank (the Bank) is pleased to celebrate its 75th anniversary with a series of events starting with a landmark exhibition, “From Shanghai to Hong Kong, Connecting the World”, which will be open to the public from 8 November to 5 December 2025. The exhibition chronicles the Bank’s storied journey from its origin in Shanghai to its incorporation in Hong Kong, showcasing decades of pioneering banking services and its abiding commitment to connecting customers internationally. The Bank currently has presence in major financial hubs such as New York, San Francisco, Los Angeles, London, Shanghai, and Shenzhen. This international reach is further strengthened by the Bank’s strategic Tribank alliance with Bank of Shanghai* in Chinese Mainland and The Shanghai Commercial and Savings Bank^ in Taiwan, creating a combined network of over 400 outlets across China, Southeast Asia, as well as the United Kingdom and the United States.

Visitors can print their own 75th Anniversary Time Cheque in different currencies and amounts as a special souvenir.
Visitors can print their own 75th Anniversary Time Cheque in different currencies and amounts as a special souvenir.

The exhibition features a curated collection of 75 exhibits, documents, photographs and interactive displays that illuminate the Bank’s rich heritage. The journey began in 1915 when The Shanghai Commercial and Savings Bank was established, which later became the largest privately-run bank# in China. In 1927, China Travel Service was established as a subsidiary. In 1933, its representative office was established in Hong Kong, which was then upgraded the following year to a full Hong Kong Branch. In 1950, this branch was locally incorporated as Shanghai Commercial Bank and has since grown into a modern international financial institution with 50 branches and offices worldwide. These exhibits, drawn from the Bank’s own archives, offer a unique glimpse into the evolution of banking in Hong Kong.

Visitors will have an exclusive opportunity to view historical items, many of which are being shown to the public for the first time, including:

  • A replica of the massive 1931 Vault Door from the original Shanghai Head Office, embodying the grandeur, trust and security of classic banking. This gateway connects the visitor to the world.
  • Intricate architectural models of the Bank’s iconic buildings, including the 1968 Hong Kong Head Office in Central and its overseas branches.
  • A Cheque Writer machine, used for printing secure cashier’s cheques in the 1970s and 1980s. Visitors can print their own 75th Anniversary Time Cheque in different currencies and amounts as a special souvenir.

The exhibition is not just a reflection on the past but also a window to the future. A dedicated Digital Experience Zone will feature the interactive installation “AI Chief Executive”, which showcases the Bank’s digital vision and latest fintech applications. Visitors can engage in a dynamic dialogue with our AI-powered Chief Executive to discover how fintech is shaping the future of banking.

A Legacy of Visionary Banking

Mr. Wallace LAM Wing-ted, Chief Executive of Shanghai Commercial Bank, said, “For 75 years, Shanghai Commercial Bank has grown alongside Hong Kong, fostering deep trust and long-term relationships with our customers that span generations and geographies. Through the Tribank alliance with Bank of Shanghai in Chinese Mainland and The Shanghai Commercial and Savings Bank in Taiwan, we help customers expand their business, investment, and personal banking reach, connecting them to opportunities across China, Southeast Asia, the United Kingdom and the United States.

“This exhibition presents a comprehensive narrative of our Bank’s historical journey and future vision. We reflect on the foresight of our founder, Mr. CHEN Kwang-pu, who laid a solid foundation through his mission to drive industrial and commercial development and to foster financial inclusion. Today, while serving our local community with dedication, we are actively expanding into global opportunities, steadfast in our commitment to providing customers with premium services. Looking ahead, we will continue to build on our traditional strengths while embracing innovation and technology. Staying true to our founding purpose, we will move forward steadily in a rapidly changing environment, creating lasting value for our customers and society.”

Shanghai Commercial Bank 75th Anniversary Exhibition

Theme: From Shanghai to Hong Kong, Connecting the World
傳承滬港‧連繫國際
Dates: 8 November to 5 December 2025
Venues: 2/F & 27/F, Shanghai Commercial Bank Tower, 12 Queen’s Road Central
Admission: Free (Online registration is required for access to the 27/F exhibition area)
Guided Tours: Reservations must be made through online registration. Further details will be provided shortly

About the 75th Anniversary Logo
The 75th Anniversary logo features a primary colour palette combining the Bank’s distinctive red with purple, which represents Hong Kong in the proud Tribank branding. The numeral “75” is designed to resemble both a ribbon and a petal, symbolising the Bauhinia flower. This design underscores the inseparable bond between Shanghai Commercial Bank and Hong Kong, seamlessly integrating the Bank’s identity with its milestone celebrations. Embracing the spirit of adaptability and innovation embodied by the ribbon, the Bank moves forward to explore new possibilities, creating lasting value for society, customers, employees, and the Bank itself.

Hashtag: #ShanghaiCommercialBank

The issuer is solely responsible for the content of this announcement.

About Shanghai Commercial Bank

Incorporated in Hong Kong in 1950 and recognised as one of the city’s most distinguished local Chinese banks, Shanghai Commercial Bank has built on its strengths in serving corporations, small and medium-sized enterprises (SMEs), and high-net-worth individuals. Tracing its roots to The Shanghai Commercial Savings Bank founded by Mr. CHEN Kwang-pu in 1915, the Bank is dedicated to serving the community with tailor-made services through a global network of 50 branches and offices in Hong Kong, New York, San Francisco, Los Angeles, London, Shanghai and Shenzhen. It offers a comprehensive range of banking products and services, including loans, deposits, trade finance, remittances, securities trading, wealth management, insurance, treasury, foreign exchange, credit cards, and digital banking solutions.

In 2000, the Bank formed a strategic alliance with Bank of Shanghai* in Chinese Mainland and The Shanghai Commercial and Savings Bank^ in Taiwan, creating the Tribank branding with a combined network of more than 400 outlets spanning China, Southeast Asia, the United Kingdom and the United States.

* Bank of Shanghai Company Limited is a registered banking institution in Chinese Mainland, and does not hold a banking license in Hong Kong, and hence is not under the supervision of the Hong Kong Monetary Authority, but holds a wholly-owned subsidiary – Bank of Shanghai (Hong Kong) in Hong Kong.
^ The Shanghai Commercial & Savings Bank Limited is a banking institution registered in Taiwan, which has branch presence in Hong Kong.
# By 1930, The Shanghai Commercial & Savings Bank had become the leading privately-run bank in China by deposit volume.

The world’s first electric car without metals or minerals is launched – and it doesn’t work

By
Advertorial Desk
-

What happens if electric vehicles and renewable energy technologies like wind turbines and solar panels suddenly had to be produced entirely without resources from mining? eNimon, the first electric car ever made without metals or minerals, answers that question.

STOCKHOLM, Oct. 27, 2025 /PRNewswire/ — More than 90 percent of an average electric car consists of resources derived from mining. eNimon, or the Nomine car, is stripped from all of these materials. It is completely transparent, lacks all characteristics that make a car a car, and it can’t move an inch. Simply put, it shows a future without access to mined metals and minerals.

 

 

The eNimon – a bold installation that highlights the importance of mining for EV production

 

“Without mining, there are no EVs, no wind turbines, no solar panels,” says Mats Eriksson, President at Business Area Mining at Sandvik. “Sustainable mining is the backbone of the green transition and fundamental to achieving global sustainability goals.”

The world is facing a critical challenge in its push toward sustainability: current mining output cannot meet the rapidly rising demand for the minerals essential for clean energy technologies. Electric vehicles (EVs), wind turbines and solar panels all depend on critical materials like lithium, copper and nickel, yet the supply of these resources is falling dangerously behind demand.

For example:

  • An EV requires six times the mineral inputs of a conventional vehicle.
  • An onshore wind plant needs nine times more mineral resources than a gas-fired plant.
  • Meeting net-zero goals by 2050 would require up to five times more production of lithium, nickel and cobalt compared to today’s levels.

Without scaling up sustainable mining practices material shortages are likely threatening not only climate targets but also global electrification and decarbonization efforts.

Sandvik is addressing this urgent issue by spotlighting the essential role of sustainable mining in creating the technologies that define modern life and drive the electrification of the world. eNimon ‘The nomine car’ installation, now on display at the National Museum of Science and Technology in Stockholm, Sweden, offers a thought-provoking visualization of what happens if these critical materials are no longer available.

“eNimon symbolizes what’s at stake if the world fails to recognize and expand mining’s essential contributions to sustainable development. This installation challenges perceptions of mining—not as a dirty, outdated industry, but as a high-tech, innovative and essential enabler of the green technologies shaping our future” Mats Eriksson concludes.

For more information about eNimon and how Sandvik is driving innovation in mining, visit home.sandvik/nominecar

Sandvik Group

Sandvik is a global, high-tech engineering group providing solutions that enhance productivity, profitability and sustainability for the manufacturing, mining and infrastructure industries. We are at the forefront of digitalization and focus on optimizing our customers’ processes. Our world-leading offering includes equipment, tools, services and digital solutions for machining, mining, rock excavation and rock processing. In 2024 the Group had approximately 41,000 employees and revenues of about SEK 123 billion in more than 150 countries.

 

Sandvik's new installation, the eNimon, which is the first electric car ever made without metals or minerals.
Sandvik’s new installation, the eNimon, which is the first electric car ever made without metals or minerals.

 

 

A dedicated Sandvik engineer walks around the eNimon, assessing the eNimon, which highlights the critical, often unseen, reliance on robust mining infrastructure to power the EV future.
A dedicated Sandvik engineer walks around the eNimon, assessing the eNimon, which highlights the critical, often unseen, reliance on robust mining infrastructure to power the EV future.

 

 

Video – https://mma.prnasia.com/media2/2804945/eNimon.mp4

1...1,9631,9641,965...6,420Page 1,964 of 6,420